1. Sweden Stocks

  2. •

    Basic Materials

  3. •

    Chemicals
XP Chemistries AB (publ)

XP Chemistries AB (publ)

XPC.ST
XP Chemistries AB (publ)SE flagStockholm Stock Exchange
0.18
SEK
-0.01
- -
34.81MMarket Cap
XP Chemistries AB (publ)
XPC.ST
(Stockholm Stock Exchange)

Recent

price

0.18

P/E

ratio

- -

div

yld

- -

ROIC.AI

2019
2020
2021
2022
2023
2024
2025
TTM
FRC
- -
- -
0.01
0.04
0.02
- -
- -
- -
Revenue per Share
- -
- -
-0.15
-0.31
-0.25
-0.07
-0.03
-0.04
Basic EPS, GAAP
- -
- -
-0.27
-0.46
-0.36
-0.08
-0.04
-0.04
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
-0.41
0.03
0.04
0.1
0.04
0.04
0.04
Book Value per Share
- -
- -
0.85
0.87
0.55
0.12
0.12
0.12
Tangible Book Value per Share
- -
20
30
26
32
108
248
237
Basic Weighted Avg Shares
- -
- -
- -
1
1
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
-1,875.06
-933.67
-1,522.75
-3,144.34
-3,224.31
-3,214.88
Operating Margin (%)
- -
- -
- -
1
1
1
2
2
Depreciation Expense
- -
- -
-5
-8
-8
-7
-9
-9
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
-1,626.81
-749.81
-1,211.26
-2,512.39
-2,602.56
-2,586.12
Profit Margin (%)
- -
- -
21
16
9
4
16
13
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
- -
- -
31
29
26
22
37
34
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
-896.95
-391.85
-178.8
-111.04
-108.01
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
199
199
314
Market Capitalization
45
34
44

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
20
18
15
Cash, Cash Equivalents & STI
18
15
12
Accounts Receivable, Net
- -
- -
- -
Inventories
2
2
2
Total Current Liabilities
1
1
2
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
12,507.71%
71.3%
Free Cash Flow
- -
- -
7.61%
Net Income, GAAP
- -
- -
19.44%
Sales/Revenue/Turnover
- -
- -
15.31%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.02
-0.02
-0.02
-0.01
-0.07
2025
-0.01
-0.01
-0.01
- -
-0.03
2026
-0.01
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Hunan Kaimeite Gases Co., Ltd. (002549.SZ)
Black Swan Graphene Inc. (BSWGF)
GRIPM Advanced Materials Co., Ltd. (688456.SS)
Sichuan Hebang Biotechnology Corporation Limited (603077.SS)
Newtrend Group Holding Co. Ltd. (2573.HK)
Anhui Guofeng New Materials Co., Ltd. (000859.SZ)
Business
XP Chemistries AB (publ) XP Chemistries AB (publ) (XPC.ST), a Sweden-based biotechnology company founded in 2018 and headquartered in Sundsvall, develops and produces sustainable, forest-based capsaicin and analogues using patented, eco-friendly catalytic processes from renewable biomass; it offers animal feed ingredients to reduce antibiotic use, personal care and cosmetic ingredients, pure capsaicinoids for life sciences and dietary supplements including the Precise HEAT brand, and self-defense spray ingredients, with operations spanning Europe and North America targeting animal farming, pharmaceuticals, cosmetics, and industrial applications. The company holds a comprehensive international patent portfolio for nature-inspired technologies aimed at UN sustainable development goals, such as green pharmaceutical intermediates and accessible natural flavors. Recent developments include receiving product orders such as SEK 220,000 in value and for Precise HEAT, narrowing operating losses in Q2 and Q3 2025 to SEK 2.1-2.2 million, ensuring full utilization of TO2 subscription options via bonds and guarantees, appointing Anders Frejdh as returning CFO and Patrik Fagerholm previously, insider purchases by CEO Erik Nelsson, and submitting capsaicin information for EFSA animal feed approval, alongside regular interim reports like the January-September 2025 release.